국내 의료기관에서 종양약료서비스 현황과 전문약사의 역할 = Current Status of Oncology Pharmacy Service and Role of Certified Oncology Pharmacists in Korean Hospitals

다국어 초록 (Multilingual Abstract)

Background : The Korean Society of Health-System Pharmacists conducted the first certified oncology pharmacist examination in 2010. Currently, there are more than 180 certified oncology pharmacists in Korea. The purpose of this study was to investigate the current status of oncology pharmacy service and the role of pharmacists and suggest future paths for certified oncology pharmacists in Korea.
Methods : The survey was conducted on pharmacists working at oncology pharmacies, as well as doctors and nurses with oncology pharmacy services experience. Additionally, the focus group interview was conducted with certified oncology pharmacists to evaluate pharmacists’needs regarding improving the certified pharmacist system.
Results : The survey was completed by 99 pharmacists, 33 doctors, and 65 nurses in 33 hospitals.
Among the certified oncology pharmacists currently working, the percentage of those who work specifically in oncology pharmacies was 24.9%. Oncology pharmacy services comprise prescription review and intervention, medication history management, attending round and conference, education, quality improvement activity and research activity. When asked about the services provided by oncology pharmacists, the medical staff responded with prescription review and intervention, providing drug information, patient education, therapeutic drug monitoring consulting, adverse drug reaction monitoring, and medication history management. And the medical staff showed more than average satisfaction in each service field. In the focus group interview, similar findings were confirmed. Meanwhile, dissatisfactory factors included the combination of clinical and dispensing tasks, discontinuity of work due to department circulation, and difficulties caused by lack of manpower.
Conclusions : The results show that certified oncology pharmacists were performing more advanced services than general pharmacists. Also, the medical staffs were fully aware of the oncology pharmacy services and satisfied with such services. However, the current certified pharmacist system has a limitation in that it lacks laws as well as a compensation system.

참고문헌 (Reference)

• 1 병원약학교육연구원, "종양약료 전문약사 소개" 병원약학교육연구원
• 2 Hematology/Oncology Pharmacy Association, "The role of hematology/oncology pharmacists"
• 3 Suzuki S, "The impact of pharmacist certification on the quality of chemotherapy in Japan" 38 (38): 1326-1335, 2016
• 4 Hematology/Oncology Pharmacy Association, "Scope of Hematology/Oncology Pharmacy Practice"
• 5 Iihara H, "Pharmacists contribute to the improved efficiency of medical practices in the outpatient cancer chemotherapy clinic" 18 (18): 753-760, 2012
• 6 Center NC, "National Cancer Center Hospital 2018"
• 7 "Japanese Society of Pharmaceutical Oncology homepage"
• 8 "Japanese Society of Pharmaceutical Health Care and Sciences homepage"
• 9 "Japanese Society of Hospital Pharmacists homepage"
• 10 Ishikawa K, "Graduate Programs in Advanced Pharmacy Practice in Oncology in Japan" 74 (74): 111-, 2010
• 11 Ignoffo R, "Board-Certified Oncology Pharmacists: Their Potential Contribution to Reducing a Shortfall in Oncology Patient Visits" 12 (12): e359-e368, 2016
• 12 Board of Pharmacy Specialties, "BPS Content Outline"
• 13 Board of Pharmacy Specialties, "BPS Annual Reports"
• 14 Shank BR, "Advances in oncology pharmacy practice" 72 (72): 2098-2100, 2015
• 15 Imamura M, "A retrospective study of the effects of oncology pharmacist participation in treatment on therapeutic outcomes and medical costs" 40 (40): 1956-1962, 2017
• 16 보건복지부, "2016년 국가암등록통계 참고자료" 보건복지부